Expression of γH2AX may help in defining a genetically more stable subtype of infiltrating ductal carcinoma of breast

Indian Journal of Medical Research

Volumn 137, Issue 4, 2013, Pages 759-766

  Bhatia, Alka ^a   Dey, Pranab ^a   Goel, Shubham ^a   Singh, Gurpreet ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

H2AX; Apoptosis; Cytology; Fibroadenoma; Grading; IDC; Ploidy

Indexed keywords

GAMMA HISTONE H2AX; HISTONE H2AX; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST FIBROADENOMA; CANCER GRADING; CANCER INFILTRATION; CELL STRUCTURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; PAGET NIPPLE DISEASE; PLOIDY; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADULT; BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA, DUCTAL; FEMALE; FIBROADENOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877791357     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone h2ax phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-68.
2. Yu T, MacPhail SH, Banáth JP, Klokov D, Olive PL. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. DNA Repair (Amst) 2006; 5: 935-46.
3. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Nussenzweig A, Bonner WM. Characteristics of gamma-H2AX foci atDNA double-strand breaks sites. Biochem Cell Biol 2003; 8: 123-9.
4. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003; 5: 675-9.
5. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003; 114: 371-83.
6. Liu Y, Parry JA, Chin A, Duensing S, Duensing A. Soluble histone H2AX is induced by DNA replication stress and sensitizes cells to undergo apoptosis. Mol Cancer 2008; 7: 61.
7. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, liloglou T, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434: 907-13.
8. Blanco D, Vicent S, Fraga MF, Fernandez-Garcia I, Freire J, lujambio A, et al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia 2007; 9: 840-52.
9. Wasco MJ, Pu RT.Utility of antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma. Appl Immunohistochem Mol Morphol 2008; 16: 349-56.
10. Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V, et al. Invasive breast carcinoma. In Fattaneh A, Tavassoli FA, Devillee P, edtiors. WHO classification of tumours: Pathology and genetics of tumours of the breast and female genital organs. lyon: IARC Press; 2003. p. 13-62.
11. Hsu HM, Wang HC, Chen ST, Hsu GC, Shen CY, Yu LC. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomarkers Prev 2007; 16: 2024-32.
12. Bartkova J, Horejsi Z, Koed K, Krämer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-70.
13. Bartkova J, Bakkenist CJ, Rajpert-De Meyts E, Skakkebaek NE, Sehested M, lukas J, et al. ATM activation in normal human tissues and testicular cancer. Cell Cycle 2005; 4: 838-45.
14. Cheung WL, Albadine R, Chan T, Sharma R, Netto GJ. Phosphorylated H2AX in noninvasive low grade urothelial carcinoma of the bladder: Correlation with tumor recurrence. J Urol 2009; 181: 1387-92.
15. Robinson JA, McKee G, Nichoson A, D'Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine needle aspirates from breast carcinomas. Lancet 1994; 343: 947-49.
16. Jeggo PA, lobrich M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 2007; 26: 7717-9.
17. Yang SX, Nguyen D, Steinberg SM, Ji J, Parchment R, Kinders R, et al. Quantitative immunohistochemical detection of gamma-H2AX in paraffin-embedded human tumor samples at National Clinical Target Validation laboratory. American Society of Clinical Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 2007; 25 (Suppl): 10565.
18. Helleday T, Petermann E, lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 2008; 8: 193-204.
19. Wasco MJ, Pu RT, Yu L, Su L, Ma L. Expression of gamma-H2AX in melanocytic lesions. Hum Pathol 2008; 39: 1614-20.
20. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-stranded breaks in vivo. J Cell Biol 1999; 146: 905-16.
21. Wasco JM, Pu RT. Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (γ-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration. Diagn Cytopathol 2008; 36: 568-73.
22. Srivastava N, Gochhait S, Gupta P, Bamezai RN. Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet Cytogenet 2008; 180: 121-8.
23. Hau PK, Siu WY, Wong N, lai PBS, Poon RY. Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cells. FEBS Lett 2006; 580: 4727-36.
24. Munteanu D, Zlei M, Ailiesei O, Chifu C, Diaconu C, Carasevici E. Flowcytometric evidence of DNA ploidy in human breast cancer. J Prev Med 2004; 12: 59-65.
25. Chassevent A, Jourdan ML, Romain S, Descotes F, Colonna M, Martin PM, et al. S-Phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Clin Cancer Res 2001; 7: 909-12.
26. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139.J Biol Chem 2000; 275: 9390-5.
27. Solier S, Pommier Y. The apoptotic ring: a novel entity with phosphorylated histones H2AX and H2B and activated DNA damage response kinases. Cell Cycle 2009; 8: 1853-9.
28. Vakkala M, lahteenmaki K, Raunio H, Paakko P, Soini Y. Apoptosis during breast carcinoma progression. Clin Cancer Res 1999; 5: 319-24.
29. Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H. Breast cancer in young women: Poor survival despite intensive treatment. PLOS One 2009; 4: e7695.